| Biliary Disease |
1 |
1 |
| Ascites |
0 |
0.66 |
| Refractory |
0 |
0.53 |
| Malignant Ascites |
0 |
0.51 |
| Renal Failure |
0 |
0.46 |
| Acute Kidney Injury |
0 |
0.39 |
| Hyponatremia |
0 |
0.31 |
| Transjugular Intrahepatic Portosystemic Shunt Procedure |
0 |
0.99 |
| Transjugular Intrahepatic Portosystemic Shunt |
0 |
0.98 |
| Liver |
0 |
0.2 |
| Model for End-Stage Liver Disease |
0 |
0.2 |
| Paracentesis |
0 |
0.2 |
| End-Stage Liver Disease |
0 |
0.19 |
| Liver Disease |
0 |
0.19 |
| Wound Management |
0 |
0.15 |
| Abdominal Infection |
0 |
0.13 |
| Cirrhosis |
0 |
0.97 |
| Injury |
0 |
0.13 |
| Kidney |
0 |
0.13 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.11 |
| Platelet Count |
0 |
0.11 |
| Primary Bacterial Peritonitis |
0 |
0.09 |
| Hypertension |
0 |
0.08 |
| Diuretics |
0 |
0.07 |
| Dorsum |
0 |
0.07 |
| Endocrinology |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Orbit |
0 |
0.07 |
| Peritonitis |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Referral |
0 |
0.07 |
| Residency |
0 |
0.07 |
| Tissue |
0 |
0.07 |
| Transplantation |
0 |
0.07 |